130 related articles for article (PubMed ID: 38356778)
1. A validated liquid chromatography-tandem mass spectrometry assay for the analysis of isoniazid and its metabolite acetyl-isoniazid in urine.
Maputla SP; Van Dalen W; Joubert A; Norman J; Castel S; van der Merwe M; Wiesner L
J Mass Spectrom Adv Clin Lab; 2024 Apr; 32():11-17. PubMed ID: 38356778
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of UHPLC-MS/MS assay for rapid determination of a carvone Schiff base of isoniazid (CSB-INH) in rat plasma: application to pharmacokinetic study.
Iqbal M; Bhat MA; Shakeel F
Biomed Chromatogr; 2015 Jun; 29(6):876-82. PubMed ID: 25378280
[TBL] [Abstract][Full Text] [Related]
3. Quantification of isoniazid and acetylisoniazid in rat plasma and alveolar macrophages by liquid chromatography-tandem mass spectrometry with on-line extraction.
Ng KY; Zhou H; Zhang YL; Hybertson B; Randolph T; Christians U
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):188-98. PubMed ID: 17070115
[TBL] [Abstract][Full Text] [Related]
4. A simplified method for detecting isoniazid compliance in patients receiving antituberculosis chemotherapy.
Hashiguchi M; Ohno K; Sakuma A; Hino F; Tanaka T; Ohtsuji M; Matsumoto N; Yanase K; Urae A; Hosogai Y; Sato N; Yazaki A; Matsuda K; Yamazaki K; Rikihisa T
J Clin Pharmacol; 2002 Feb; 42(2):151-6. PubMed ID: 11831537
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of first-line anti-tuberculosis drugs and one metabolite of isoniazid by liquid chromatography/tandem mass spectrometry in patients with human immunodeficiency virus-tuberculosis coinfection.
Xing Y; Yin L; Le X; Chen J; Zhang L; Li Y; Lu H; Zhang L
Heliyon; 2021 Jul; 7(7):e07532. PubMed ID: 34296020
[TBL] [Abstract][Full Text] [Related]
6. Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships.
Ulanova V; Kivrane A; Viksna A; Pahirko L; Freimane L; Sadovska D; Ozere I; Cirule A; Sevostjanovs E; Grinberga S; Bandere D; Ranka R
Front Pharmacol; 2024; 15():1332752. PubMed ID: 38584604
[No Abstract] [Full Text] [Related]
7. Preclinical pharmacokinetics, tissue distribution and excretion studies of a novel anti-candidal agent-thiosemicarbazide derivative of isoniazid (TSC-INH) by validated UPLC-MS/MS assay.
Iqbal M; Ezzeldin E; Bhat MA; Raish M; Al-Rashood KA
J Pharm Biomed Anal; 2016 Jan; 117():109-17. PubMed ID: 26355768
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
Prasad B; Singh S
J Pharm Biomed Anal; 2010 Jul; 52(3):377-83. PubMed ID: 19692195
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in children.
Amlabu V; Mulligan C; Jele N; Evans A; Gray D; Zar HJ; McIlleron H; Smith P
Int J Tuberc Lung Dis; 2014 May; 18(5):528-30. PubMed ID: 24903787
[TBL] [Abstract][Full Text] [Related]
10. Isoniazid Acetylation Phenotyping in the Japanese: The Molar Metabolic Ratio INH/AcINH.
Kohno H; Kubo H; Takada A; Mori M; Arias TD
Am J Ther; 1996 Jan; 3(1):74-78. PubMed ID: 11856999
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population.
Chen B; Shi HQ; Feng MR; Wang XH; Cao XM; Cai WM
Front Pharmacol; 2022; 13():932686. PubMed ID: 35928262
[No Abstract] [Full Text] [Related]
12. Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine.
Abouzid M; Kosicka-Noworzyń K; Karaźniewicz-Łada M; Rao P; Modi N; Xie YL; Heysell SK; Główka A; Kagan L
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257250
[TBL] [Abstract][Full Text] [Related]
13. Isoniazid and acetylisoniazid kinetics in serum and urine in pulmonary primary complex with intermittent regimen.
Seth V; Seth SD; Beotra A; Semwal OP; D'monty V; Mukhopadhya S
Indian Pediatr; 1994 Mar; 31(3):279-85. PubMed ID: 7896362
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of liquid chromatography tandem mass spectrometry method for simultaneous quantification of first line tuberculosis drugs and metabolites in human plasma and its application in clinical study.
Hee KH; Seo JJ; Lee LS
J Pharm Biomed Anal; 2015 Jan; 102():253-60. PubMed ID: 25459921
[TBL] [Abstract][Full Text] [Related]
15. Solid-phase extraction and HPTLC determination of isoniazid and acetylisoniazid in serum. Comparison with HPLC.
Guermouche S; Guermouche MH
J Chromatogr Sci; 2004; 42(5):250-3. PubMed ID: 15189597
[TBL] [Abstract][Full Text] [Related]
16. Cell Type-Specific Roles of CD38 in the Interactions of Isoniazid with NAD
Zhu J; Lu J; Tung HC; Liu K; Li J; Grant DM; Xie W; Ma X
Drug Metab Dispos; 2020 Dec; 48(12):1372-1379. PubMed ID: 33020065
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic analysis of isoniazid, acetylisoniazid, and isonicotinic acid in healthy volunteers.
Seng KY; Hee KH; Soon GH; Chew N; Khoo SH; Lee LS
Antimicrob Agents Chemother; 2015 Nov; 59(11):6791-9. PubMed ID: 26282412
[TBL] [Abstract][Full Text] [Related]
18. Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
Herrera-Pérez IG; Rodríguez-Báez AS; Ortiz-Álvarez A; Velarde-Salcedo R; Arriaga-García FJ; Rodríguez-Pinal CJ; Romano-Moreno S; Milán-Segovia RDC; Medellín-Garibay SE
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123801. PubMed ID: 37453389
[TBL] [Abstract][Full Text] [Related]
19. Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.
Ammari WG; Al-Qadhi Z; Khalil M; Tayyem R; Qammaz S; Oriquat G; Basheti IA; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):202-10. PubMed ID: 25229261
[TBL] [Abstract][Full Text] [Related]
20. Application of the isoniazid assay in dried blood spots using the ultra-performance liquid chromatography-tandem mass spectrometry.
Lee K; Jun SH; Choi MS; Song SH; Park JS; Lee JH; Park KU; Song J
Clin Biochem; 2017 Oct; 50(15):882-885. PubMed ID: 28427917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
